- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04907955
Visual Performance Following Implantation of Presbyopia Correcting IOLs
May 25, 2021 updated by: magda torky, Dar Al Shifa Hospital
Visual Performance Following Implantation of 3 Presbyopia Correcting Intraocuar Lenses
The purpose of the current study was to compare the visual performance after bilateral implantation of the Panoptix IOL , or the AT LISA IOL or Tecnis Symfony IOL .
The focus was on intermediate vision, defocus curves, and contrast sensitivity.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kuwait, Kuwait
- Daralshifa hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with normal ocular examination apart from cataract.
Exclusion Criteria:
- previous ocular surgery.
- ocular pathology or corneal abnormalities.
- an endothelial cell count below 2000 cells/mm2.
- corneal astigmatism greater than 1.0 diopter (D) measured with Scheimpflug tomography (Sirius, CSO, Italy).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: panoptix PANFOCAL intraocular lens
panoptix PANFOCAL intraocular lensis a single-piece aspheric non-apodized diffractive panfocal IOL that distributes light energy to three focal points in both small and large pupil conditions
|
cataract extraction with phacoemulsification and insertion of presbyopia correcting IOL
|
Active Comparator: Trifocal Diffractive the AT LISA intraocular lens
Trifocal Diffractive the AT LISA is a preloaded single-piece aspheric diffractive trifocal IOL and made of hydrophilic acrylic with a hydrophobic surface with an ultraviolet absorber.
This aspheric IOL is aberration -correcting in order to reduce and compensate for corneal spherical aberrations.
|
cataract extraction with phacoemulsification and insertion of presbyopia correcting IOL
|
Active Comparator: Symphony EDOF (extended depth of focus) intraocular lens
SYMPHONY EDOF intraocular lens is a single-piece aspheric biconvex hydrophobic acrylic IOL with a 6.0 mm optic and an 13.0 mm overall diameter.
This IOL consists of a wavefront-designed anterior aspheric surface (negative spherical aberration of -0.27 mm to counterbalance the net positive spherical aberration from cornea) and a posterior achromatic diffractive surface with echelette design.
|
cataract extraction with phacoemulsification and insertion of presbyopia correcting IOL
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
visual acuity
Time Frame: 6 months postoperatively.
|
The monocular uncorrected (UDVA) and corrected (CDVA) distance visual acuity (4 m), uncorrected intermediate visual acuity (UIVA) (60 cm and 80 cm), distance-corrected intermediate visual acuity (DCIVA), uncorrected near visual acuity (40 cm), and distance-corrected near visual acuity (DCNVA) were assessed.
Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 4 m, 80 cm, and 40 cm.
|
6 months postoperatively.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
defocus curve
Time Frame: 6 months postoperatively.
|
The binocular defocus curve was done to evaluate the functional range of vision.
The curve was obtained while the patient wearing his distance correction to provide the best distance visual acuity in both eyes.
The test was performed under photopic conditions (85 candelas/m2) using ETDRS charts at a distance of 4m with the introduction of defocusing lenses from +1.00 D to -4.00 D in 0.50 D steps.
|
6 months postoperatively.
|
contract senstivity
Time Frame: 6 months postoperatively.
|
The CSV-1000 system (Vector Vision Inc. Greenville, OH, USA) was used to measure contrast sensitivity under photopic and mesopic conditions without glare with spatial frequencies ranging between 3 and 18 cycles/degree.
|
6 months postoperatively.
|
photic phenomena
Time Frame: 6 months postoperatively.
|
The presence of dysphotopsia including haloes, glare and starburst were assessed regarding their frequency, severity and the degree of bother.
|
6 months postoperatively.
|
spectacle independence
Time Frame: 6 months postoperatively.
|
patients were given a questionnaire to assess their spectacle independence.
The response for spectacle independence was yes or no.
|
6 months postoperatively.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Actual)
May 30, 2020
Study Completion (Actual)
May 30, 2020
Study Registration Dates
First Submitted
May 21, 2021
First Submitted That Met QC Criteria
May 25, 2021
First Posted (Actual)
June 1, 2021
Study Record Updates
Last Update Posted (Actual)
June 1, 2021
Last Update Submitted That Met QC Criteria
May 25, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 02282021065727
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Impairment
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; University Ghent; Research Foundation Flanders; Free University of Brussels and other collaboratorsUnknowniVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment (iVision)Visual Perceptual Weakness (Disorder) | Cerebral Visual ImpairmentBelgium
-
Novartis PharmaceuticalsCompletedNeovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNVGermany
-
Universitaire Ziekenhuizen KU LeuvenVrije Universiteit Brussel; Fund for Scientific Research, Flanders, BelgiumRecruitingCerebral Visual ImpairmentBelgium
-
Russell L. WoodsResearch to Prevent Blindness / Lions Club International FoundationNot yet recruitingCentral Visual Impairment
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Clinique Rive GaucheCompletedVisual Impairment in ChildrenFrance
-
Nantes University HospitalTerminatedCentral or Peripheral Visual ImpairmentFrance
-
VA Office of Research and DevelopmentCompletedScotoma, Central | Central Visual ImpairmentUnited States
-
University Health Network, TorontoNot yet recruitingStroke | Cognitive Impairment | Virtual Reality | Visual Impairment | Low Vision | Driving Impaired | Visual Spatial Processing | Visual Processing Speed | Visual Field DefectCanada
Clinical Trials on phacoemulsification with implantation of presbyopia correcting IOL
-
Xuhua TanRecruitingCataract | High MyopiaChina
-
Alcon ResearchCompletedPresbyopia | AphakiaChina
-
Alcon ResearchCompleted
-
Medical University of ViennaTerminatedPrimary Open Angle Glaucoma | Pseudoexfoliative Glaucoma
-
University of California, San DiegoWithdrawn
-
Singapore National Eye CentreCompleted
-
Alcon ResearchCompleted
-
University of Turin, ItalyUnknown
-
Haotian LinUnknownCataract | Corneal Endothelial Keratopathy | Phacoemulfisication+IOL Implantation | Endothelial KeratopathyChina
-
Military Institute of Medicine, PolandCompletedGlaucoma, Open-Angle | Glaucoma, Primary Open Angle | Glaucoma Secondary